KemPharm
KemPharm, Inc.
2500 Crosspark Rd,
Coralville, IA 52241
Phone: (888) 958 1253Website: https://kempharm.com/Careers: kempharm.com/company/careers
Latest news
- Open Label Safety Study Shows Improved Sleep for Children With ADHD After One Month of Azstarys
21 September 2022 - FDA Approves Azstarys (serdexmethylphenidate and dexmethylphenidate) Capsules for the Once-Daily Treatment for ADHD
2 March 2021 - KemPharm Submits KP415 NDA to the FDA for the Treatment of ADHD
2 March 2020
Drugs Associated with KemPharm, Inc.
KemPharm, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Apadaz
Generic name: acetaminophen/benzhydrocodone Drug class: narcotic analgesic combinations |
||
|
Azstarys
Generic name: dexmethylphenidate/serdexmethylphenidate Drug class: CNS stimulants |
30 reviews | 7.4 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
